Advertisement
Australia markets closed
  • ALL ORDS

    7,837.40
    -100.10 (-1.26%)
     
  • ASX 200

    7,575.90
    -107.10 (-1.39%)
     
  • AUD/USD

    0.6525
    +0.0002 (+0.03%)
     
  • OIL

    84.11
    +0.54 (+0.65%)
     
  • GOLD

    2,345.00
    +2.50 (+0.11%)
     
  • Bitcoin AUD

    97,129.49
    -768.32 (-0.78%)
     
  • CMC Crypto 200

    1,321.20
    -75.34 (-5.16%)
     
  • AUD/EUR

    0.6105
    +0.0031 (+0.52%)
     
  • AUD/NZD

    1.0992
    +0.0035 (+0.31%)
     
  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     
  • NASDAQ

    17,708.44
    +277.93 (+1.59%)
     
  • FTSE

    8,144.25
    +65.39 (+0.81%)
     
  • Dow Jones

    38,215.68
    +129.88 (+0.34%)
     
  • DAX

    18,162.31
    +245.03 (+1.37%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

CDC endorses Moderna's COVID vaccine for kids 6 to 17 years old

Yahoo Finance's Rachelle Akuffo looks at Moderna's stock following a CDC panel's endorsement of its latest vaccine.

Video transcript

RACHELLE AKUFFO: Well, before we go to a break, let's take a look at shares of Moderna. The CDC advisory panel endorsing the company's two-dose COVID vaccine for children ages 6 to 17 years old. The vaccine is expected to get full approval later today. The stock up almost 4 and 1/2%.